We are live on ! Find out more
ZDA

Zweig-DiMenna Associates Portfolio holdings

AUM $1.1B
1-Year Est. Return 171.86%
This Fund
S&P 500
This Quarter Est. Return
-8.15%
1 Year Est. Return
+171.86%
3 Year Est. Return
+561.39%
5 Year Est. Return
+872.04%
10 Year Est. Return
+5,051.77%
AUM
$2.31B
AUM Growth
+$497M
Cap. Flow
+$552M
Cap. Flow %
23.92%
Top 10 Hldgs %
30.83%
Holding
324
New
77
Increased
76
Reduced
52
Closed
107

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$90.9M
2
AGN
Allergan plc
AGN
+$50.4M
3
CELG
Celgene Corp
CELG
+$48.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$40M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$39.2M

Top Sells

Rank Stock Value
1
BHI
Baker Hughes
BHI
+$34.4M
2
BABA icon
Alibaba
BABA
+$25M
3
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$23.5M
4
BA icon
Boeing
BA
+$19.8M
5
AMAT icon
Applied Materials
AMAT
+$18.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.93%
2 Consumer Discretionary 12.92%
3 Miscellaneous 11.57%
4 Communication Services 10.21%
5 Technology 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIG icon
1
PUT
Transocean
RIG
$6.48B
$178M 7.71%
13,780,000
+12,580,000
+1,048% +$175M
BHI
2
DELISTED
Baker Hughes
BHI
$111M 4.79%
2,123,584
-616,802
-23% -$34.4M
BMY icon
3
Bristol-Myers Squibb
BMY
$136B
$85.5M 3.7%
1,443,723
+1,433,653
+14,237% +$90.9M
AGN
4
DELISTED
Allergan plc
AGN
$72.8M 3.15%
267,660
+164,040
+158% +$50.4M
HCA icon
5
HCA Healthcare
HCA
$90.5B
$48.7M 2.11%
630,011
+325,726
+107% +$28.8M
V icon
6
Visa
V
$712B
$45.7M 1.98%
655,632
+32,872
+5% +$2.35M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.19T
$45.1M 1.95%
1,447,180
+150,280
+12% +$4.62M
CELG
8
DELISTED
Celgene Corp
CELG
$42.6M 1.85%
+394,282
New +$48.9M
AMZN icon
9
Amazon
AMZN
$2.87T
$41.8M 1.81%
1,634,880
+711,360
+77% +$18M
META icon
10
Meta Platforms (Facebook)
META
$1.47T
$41.3M 1.79%
459,718
+25,860
+6% +$2.37M
BKNG icon
11
Booking.com
BKNG
$155B
$41.3M 1.79%
834,400
-7,300
-0.9% -$363K
TWX
12
DELISTED
Time Warner Inc
TWX
$40.4M 1.75%
587,440
-71,735
-11% -$5.63M
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$137B
$35.2M 1.53%
338,441
+311,441
+1,153% +$40M
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
$33.6M 1.46%
+214,946
New +$39.2M
BHC icon
15
Bausch Health
BHC
$2.36B
$33.3M 1.44%
186,798
+42,071
+29% +$9.81M
DHR icon
16
Danaher
DHR
$152B
$32.4M 1.4%
565,160
+37,926
+7% +$2.24M
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$12.5B
$31.2M 1.35%
296,065
+243,565
+464% +$32.5M
APC
18
DELISTED
Anadarko Petroleum
APC
$30M 1.3%
495,997
+41,573
+9% +$2.95M
SEE
19
DELISTED
Sealed Air
SEE
$29.6M 1.28%
630,657
+151,778
+32% +$7.84M
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
$29.4M 1.27%
+353,698
New +$32M
BERY
21
DELISTED
Berry Global Group, Inc.
BERY
$28.5M 1.24%
1,033,508
+358,390
+53% +$10.3M
DATA
22
DELISTED
Tableau Software, Inc.
DATA
$28.2M 1.22%
+353,748
New +$36.7M
AAPL icon
23
Apple
AAPL
$4.67T
$27.8M 1.21%
1,009,756
+114,756
+13% +$3.37M
SCU
24
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$27.4M 1.19%
313,576
+77,697
+33% +$8.36M
HLT icon
25
Hilton Worldwide
HLT
$72.4B
$27.2M 1.18%
394,757
-51,219
-11% -$3.96M
1
2 3 4 5

Similar funds

NW
Naviter Wealth Little Rock, Arkansas $1.1B AUM 33.28% 1-Year Est. Return
TFA
Teamwork Financial Advisors San Antonio, Texas $1.1B AUM 39.98% 1-Year Est. Return
TPA
Trivium Point Advisory Westport, Connecticut $1.1B AUM 28.81% 1-Year Est. Return
RA
Rodgers & Associates Lancaster, Pennsylvania $1.1B AUM 20.77% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.1B AUM 11.31% 1-Year Est. Return
PFM
Premier Fund Managers Guildford, United Kingdom $1.1B AUM 14.42% 1-Year Est. Return
DI
DUMAC Inc Durham, North Carolina $1.1B AUM

Zweig-DiMenna Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Zweig-DiMenna Associates held 324 positions worth $2.31B, up 27% from $1.81B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Zweig-DiMenna Associates deployed $552M of net new capital in Q3 2015, opening 77 new positions and adding to 76 existing holdings. Its largest new stake was Celgene Corp: 394,282 shares worth $42.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.

On the sell side, the largest reduction was Baker Hughes, an estimated $34.4M trimmed.

  • Zweig-DiMenna Associates's largest Q3 2015 buy was Celgene Corp: 394,282 shares worth $42.6M.
  • Zweig-DiMenna Associates added most to Bristol-Myers Squibb in Q3 2015, an estimated $90.9M increase.
  • Zweig-DiMenna Associates's biggest Q3 2015 reduction was Baker Hughes, cutting an estimated $34.4M.
  • Zweig-DiMenna Associates fully exited Alibaba in Q3 2015, selling an estimated $25M.
  • Zweig-DiMenna Associates's ten largest holdings make up 31% of its $2.31B portfolio in Q3 2015.
  • Zweig-DiMenna Associates opened 77 new positions and closed 107 in Q3 2015.
  • Zweig-DiMenna Associates's portfolio value rose 27% quarter-over-quarter to $2.31B.

Based on Zweig-DiMenna Associates's 13F filing for Q3 2015, filed 9 Nov 2015.